How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.
In today’s edition of The Capitals, read about Vance’s Greenland power trip being scaled back amid local backlash, the Czech ...
INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...
INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, ...
We should have learned our Listeria lessons, but the recall of plant-based beverages in 2024 shows there is still much to be done to improve food safety.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results